يعرض 1 - 10 نتائج من 899 نتيجة بحث عن '"chemically induced"', وقت الاستعلام: 1.01s تنقيح النتائج
  1. 1

    المساهمون: Easton, Douglas [0000-0003-2444-3247], Apollo - University of Cambridge Repository, Dennis, Joe [0000-0003-4591-1214]

    المصدر: Wang, X, Kapoor, P M, Auer, P L, Dennis, J, Dunning, A M, Wang, Q, Lush, M, Michailidou, K, Bolla, M K, Aronson, K J, Murphy, R A, Brooks-wilson, A, Lee, D G, Cordina-duverger, E, Guénel, P, Truong, T, Mulot, C, Teras, L R, Patel, A V, Dossus, L, Kaaks, R, Hoppe, R, Lo, W, Brüning, T, Hamann, U, Czene, K, Gabrielson, M, Hall, P, Eriksson, M, Jung, A, Becher, H, Couch, F J, Larson, N L, Olson, J E, Ruddy, K J, Giles, G G, Macinnis, R J, Southey, M C, Le Marchand, L, Wilkens, L R, Haiman, C A, Olsson, H, Augustinsson, A, Krüger, U, Wagner, P, Scott, C, Winham, S J, Vachon, C M, Perou, C M, Olshan, A F, Troester, M A, Hunter, D J, Eliassen, H A, Tamimi, R M, Brantley, K, Andrulis, I L, Figueroa, J, Chanock, S J, Ahearn, T U, García-closas, M, Evans, G D, Newman, W G, Van Veen, E M, Howell, A, Wolk, A, Håkansson, N, Anton-culver, H, Ziogas, A, Jones, M E, Orr, N, Schoemaker, M J, Swerdlow, A J, Kitahara, C M, Linet, M, Prentice, R L, Easton, D F, Milne, R L, Kraft, P, Chang-claude, J & Lindström, S 2022, ' Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women ', Scientific Reports, vol. 12, no. 1, 6199 . https://doi.org/10.1038/s41598-022-10121-2Test
    Wang, X, Kapoor, P M, Auer, P L, Dennis, J, Dunning, A M, Wang, Q, Lush, M, Michailidou, K, Bolla, M K, Aronson, K J, Murphy, R A, Brooks-Wilson, A, Lee, D G, Cordina-Duverger, E, Guénel, P, Truong, T, Mulot, C, Teras, L R, Patel, A V, Dossus, L, Kaaks, R, Hoppe, R, Lo, W-Y, Brüning, T, Hamann, U, Czene, K, Gabrielson, M, Hall, P, Eriksson, M, Jung, A, Becher, H, Couch, F J, Larson, N L, Olson, J E, Ruddy, K J, Giles, G G, MacInnis, R J, Southey, M C, Le Marchand, L, Wilkens, L R, Haiman, C A, Olsson, H, Augustinsson, A, Krüger, U, Wagner, P, Scott, C, Winham, S J, Vachon, C M, Perou, C M, Olshan, A F, Troester, M A, Hunter, D J, Eliassen, H A, Tamimi, R M, Brantley, K, Andrulis, I L, Figueroa, J, Chanock, S J, Ahearn, T U, García-Closas, M, Evans, G D, Newman, W G, van Veen, E M, Howell, A, Wolk, A, Håkansson, N, Anton-Culver, H, Ziogas, A, Jones, M E, Orr, N, Schoemaker, M J, Swerdlow, A J, Kitahara, C M, Linet, M, Prentice, R L, Easton, D F, Milne, R L, Kraft, P, Chang-Claude, J & Lindström, S 2022, ' Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women ', Scientific Reports, vol. 12, 6199 . https://doi.org/10.1038/s41598-022-10121-2Test

    وصف الملف: text/xml; application/pdf

  2. 2
  3. 3

    المساهمون: ANS - Neuroinfection & -inflammation, Neurology, ACS - Atherosclerosis & ischemic syndromes, ANS - Neurovascular Disorders, Cardiovascular Centre (CVC), Klinische Neurowetenschappen, MUMC+: MA Med Staf Spec Neurologie (9), RS: Carim - B05 Cerebral small vessel disease

    المصدر: Lancet neurology, 20(11), 907-916. Lancet Publishing Group
    Lancet Neurology, 20, 11, pp. 907-916
    Lancet Neurology, 20(11), 907-916. ELSEVIER SCIENCE INC
    The Lancet Neurology, 20(11), 907-916. Lancet Publishing Group
    Lancet Neurology, 20, 907-916
    The Lancet Neurology, 20(11), 907-916. ELSEVIER SCIENCE INC
    Lancet Neurology, 20(11), 907-916. Elsevier Science

    وصف الملف: application/pdf

  4. 4

    المساهمون: Obstetrics, UCL - (SLuc) Service d'obstétrique, UCL - SSS/IREC/SLUC - Pôle St.-Luc, Obstetrics and Gynaecology, ARD - Amsterdam Reproduction and Development

    المصدر: British Journal of Haematology, 193, 52-62
    British Journal of Haematology, 193, 1, pp. 52-62
    British journal of haematology, Vol. 193, no. 1, p. 52-62 (2021)
    British Journal of Haematology
    British journal of haematology, 193(1), 52-62. Wiley-Blackwell

    مصطلحات موضوعية: Cyclophosphamide/administration & dosage, Congenital Abnormalities/epidemiology, Antibodies, Monoclonal, Murine-Derived, 0302 clinical medicine, Antineoplastic Agents, Immunological, Lymphoma, Large B-Cell, Diffuse/complications, Prednisone, Pregnancy, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Vincristine/administration & dosage, Antineoplastic Agents, Immunological/therapeutic use, Fetal Growth Retardation/chemically induced, Fetal Growth Retardation, Obstetrics, Standard treatment, Stillbirth/epidemiology, non-Hodgkin lymphoma, Incidence, Lymphoma, Non-Hodgkin, Pregnancy Outcome, Hematology, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Stillbirth, Progression-Free Survival, 3. Good health, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], R-CHOP, Vincristine, 030220 oncology & carcinogenesis, Antibodies, Monoclonal, Murine-Derived/therapeutic use, Premature Birth, Female, pregnancy, Lymphoma, Large B-Cell, Diffuse, Rituximab, Cohort study, medicine.drug, Prednisolone/administration & dosage, Adult, medicine.medical_specialty, Lymphoma, Non-Hodgkin/diagnosis, Adolescent, Prednisolone, diffuse large B-cell lymphoma, Gestational Age, Pregnancy Outcome/epidemiology, Hodgkin Lymphoma During Pregnancy, Congenital Abnormalities, 03 medical and health sciences, Rituximab/therapeutic use, medicine, Pregnancy Complications/chemically induced, Humans, Cyclophosphamide, Retrospective Studies, business.industry, Doxorubicin/administration & dosage, Infant, Newborn, medicine.disease, maternal outcome, Pregnancy Complications, Infertility/chemically induced, Doxorubicin, Infertility, Premature Birth/chemically induced, Small for gestational age, business, Diffuse large B-cell lymphoma, 030215 immunology

    وصف الملف: application/pdf; Print-Electronic

  5. 5
  6. 6

    المساهمون: Pistre, Karine, Service of Neurology [CHUV, Lausanne, Switzerland], Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Université de Lausanne = University of Lausanne (UNIL), Neuro-Dol (Neuro-Dol), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), CHU Clermont-Ferrand, Service de neurologie [Poitiers], Centre hospitalier universitaire de Poitiers (CHU Poitiers), Service Maladies infectieuses et tropicales [CHU Toulouse], Pôle Inflammation, infection, immunologie et loco-moteur [CHU Toulouse] (Pôle I3LM Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de neurologie [Bordeaux], CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Service de médecine interne [Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Pasteur [Nice] (CHU), Université Côte d'Azur (UCA), Pôle Neurosciences [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service des maladies infectieuses et tropicales [Toulouse], Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse], Pôle neurosciences [Hôpital de Purpan - Toulouse], CHU Toulouse [Toulouse]

    المصدر: Neurology, vol. 9, no. 1, pp. e1097
    Neurology Neuroimmunology & Neuroinflammation
    Neurology Neuroimmunology & Neuroinflammation, 2022, 9 (1), pp.e1097. ⟨10.1212/NXI.0000000000001097⟩
    Neurology® Neuroimmunology & Neuroinflammation
    article-version (Version of Record) 3
    Neurology Neuroimmunology & Neuroinflammation, American Academy of neurology, 2022, 9 (1), pp.e1097. ⟨10.1212/NXI.0000000000001097⟩

    مصطلحات موضوعية: Male, MESH: Leukoencephalopathy, Progressive Multifocal / chemically induced, [SDV]Life Sciences [q-bio], MESH: CCR5 Receptor Antagonists / administration & dosage, Maraviroc, chemistry.chemical_compound, Natalizumab, Immune Reconstitution Inflammatory Syndrome, MESH: Immune Reconstitution Inflammatory Syndrome / chemically induced, Outcome Assessment, Health Care, [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, MESH: Middle Aged, Progressive multifocal leukoencephalopathy, Hazard ratio, Leukoencephalopathy, Progressive Multifocal, Middle Aged, Class IV, [SDV] Life Sciences [q-bio], MESH: Maraviroc / pharmacology, Neurology, CCR5 Receptor Antagonists, Cohort, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, MESH: CCR5 Receptor Antagonists / pharmacology, Female, medicine.drug, Adult, MESH: Immune Reconstitution Inflammatory Syndrome / drug therapy, medicine.medical_specialty, MESH: Leukoencephalopathy, Progressive Multifocal / drug therapy, Article, Multiple sclerosis, Young Adult, Immune reconstitution inflammatory syndrome, Internal medicine, medicine, Humans, MESH: Outcome Assessment, Health Care, Retrospective Studies, Viral infections, MESH: Humans, business.industry, Retrospective cohort study, MESH: Retrospective Studies, Odds ratio, medicine.disease, MESH: Male, MESH: Leukoencephalopathy, Progressive Multifocal / prevention & control, chemistry, MESH: Immune Reconstitution Inflammatory Syndrome / prevention & control, Neurology (clinical), business, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, CCR5 Receptor Antagonists/administration & dosage, CCR5 Receptor Antagonists/pharmacology, Immune Reconstitution Inflammatory Syndrome/chemically induced, Immune Reconstitution Inflammatory Syndrome/drug therapy, Immune Reconstitution Inflammatory Syndrome/prevention & control, Leukoencephalopathy, Progressive Multifocal/chemically induced, Leukoencephalopathy, Progressive Multifocal/drug therapy, Leukoencephalopathy, Progressive Multifocal/prevention & control, Maraviroc/administration & dosage, Maraviroc/pharmacology, MESH: Maraviroc / administration & dosage

    وصف الملف: application/pdf

  7. 7
  8. 8

    المصدر: Cancer research, vol. 81, no. 23, pp. 5862-5875

    وصف الملف: application/pdf

  9. 9
  10. 10

    المصدر: Buskbjerg, C R, Amidi, A, Buus, S, Gravholt, C H, Hadi Hosseini, S M & Zachariae, R 2022, ' Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypes ', Prostate Cancer and Prostatic Diseases, vol. 25, no. 2, pp. 208-218 . https://doi.org/10.1038/s41391-021-00398-1Test